CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-27 | Weinberg Uri Chief Innovation Officer | Grant or award · Stock Options (Right to buy) | +125,078 | $16.30 | $2.0M | 125,078 |
| 2024-02-27 | Leupin Nicolas Chief Medical Officer | Grant or award | +51,124 | $16.30 | $833K | 51,124 |
| 2024-02-27 | Leupin Nicolas Chief Medical Officer | Grant or award · Stock Options (Right to buy) | +78,174 | $16.30 | $1.3M | 78,174 |
| 2024-02-27 | Giladi Moshe Chief Science Officer | Grant or award | +51,124 | $16.30 | $833K | 69,771 |
| 2024-02-27 | Giladi Moshe Chief Science Officer | Grant or award · Stock Options (Right to buy) | +78,174 | $16.30 | $1.3M | 78,174 |
| 2024-02-27 | Ben Arye Barak General Counsel | Grant or award | +81,799 | $16.30 | $1.3M | 117,122 |
| 2024-02-27 | Ben Arye Barak General Counsel | Grant or award · Stock Options (Right to buy) | +125,078 | $16.30 | $2.0M | 125,078 |
| 2024-02-27 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Grant or award | +47,034 | $16.30 | $767K | 256,862 |
| 2024-02-27 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Grant or award · Stock Options (Right to buy) | +71,920 | $16.30 | $1.2M | 71,920 |
| 2023-12-31 | Ben Arye Barak General Counsel | Grant or award | +128 | $12.69 | $2K | 35,323 |
| 2023-12-31 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Grant or award | +3 | $12.69 | $38 | 209,828 |
| 2023-11-07 | Shah Pritesh Chief Growth Officer | Sale | −382 | $12.65 | $5K | 124,511 |
| 2023-11-02 | Cordova Ashley Chief Financial Officer | Exercise or conversion | +175 | $11.46 | $2K | 117,618 |
| 2023-11-02 | Cordova Ashley Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −175 | 0 | ||
| 2023-10-31 | Puri Michal Nath Chief Human Resources Officer | Grant or award | +37,593 | 37,593 | ||
| 2023-10-31 | Puri Michal Nath Chief Human Resources Officer | Grant or award · Stock Option (Right to Buy) | +57,604 | $13.30 | $766K | 57,604 |
| 2023-10-31 | Cordova Ashley Chief Financial Officer | Exercise or conversion | +7,561 | $11.46 | $87K | 107,211 |
| 2023-10-31 | Cordova Ashley Chief Financial Officer | Exercise or conversion | +2,480 | $11.44 | $28K | 109,691 |
| 2023-10-31 | Cordova Ashley Chief Financial Officer | Exercise or conversion | +7,752 | $7.15 | $55K | 117,443 |
| 2023-10-31 | Cordova Ashley Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −7,561 | 175 |
Page 12 of 20 · 399 trades